Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Acetamides 1
- administration & dosage 1
- Adolescent 2
- Adult 2
- adverse effects 1
- Aged 1
- Amantadine 1
- Animals 1
- antagonists & inhibitors 1
- Antigens, Viral / immunology 2
- Antiviral Agents 7
- Antiviral Agents / therapeutic use 10
- Child 2
- Child, Preschool 2
- Contraindications 1
- Cost of Illness 1
- Cross Infection 2
- Disease Outbreaks 6
- Disease Outbreaks / prevention & control 8
- Drug Interactions 1
- Drug Resistance, Microbial 1
- drug therapy 1
- Enzyme Inhibitors 1
- Female 1
- Guanidines 1
- HIV Infections 1
- Humans 2
- Immunization Programs 3
- Immunization Schedule 4
- Immunocompromised Host 1
- Infant 2
- Influenza 1
- Influenza, Human 13
- Influenza, Human / complications 1
- Influenza, Human / drug therapy 9
- Influenza, Human / epidemiology 3
- Influenza, Human/epidemiology 1
- Influenza, Human / prevention & control 6
- Influenza, Human/prevention & control 1
- Influenza / drug therapy 1
- Influenza A virus 10
- Influenza A Virus, H1N1 Subtype 2
- Influenza A Virus, H1N1 Subtype / immunology 2
- Influenza A Virus, H3N2 Subtype 2
- Influenza A Virus, H3N2 Subtype / immunology 2
- Influenza B virus 13
- Influenza B virus / immunology 2
- Influenza Vaccine 1
- Influenza Vaccines 8
- Influenza Vaccines / administration & dosage 12
- Influenza Vaccines/administration & dosage 1
- Influenza Vaccines / adverse effects 4
- Influenza Vaccines/adverse effects 1
- Influenza Vaccines / contraindications 1
- Influenza Vaccines / immunology 2
- Influenza Vaccines / supply & distribution 2
- Influenza Vaccines adverse effects 1
- Lyme Disease 1
- Male 1
- Mass Vaccination 9
- Middle Aged 1
- Neuraminidase 1
- Oseltamivir 1
- pharmacokinetics 1
- Pneumococcal Vaccines / administration & dosage 2
- Pneumococcal Vaccines / adverse effects 2
- Pneumonia, Viral 1
- Population Surveillance 3
- Practice Guideline 1
- Pregnancy 1
- Public Health 1
- Pyrans 1
- Rimantadine 1
- Risk Factors 1
- Seasons 3
- Seizures, Febrile / etiology 2
- Sialic Acids 1
- Silicosis 1
- therapeutic use 1
- United States / epidemiology 1
- Vaccination 8
- Vaccination / standards 8
- Vaccines, Attenuated 2
- Vaccines, Inactivated 4
- Vaccines, Inactivated / administration & dosage 1
- Vaccines, Inactivated / adverse effects 1
- Zanamivir 1
Personal Author
- Cox, Nancy (Nancy J.) (27)
Corporate Author
- Centers for Disease Control (U.S.), Immunization Practices Advisory Committee. 1
- Centers for Disease Control and Prevention (U.S.) 21
- Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Science. 1
- Centers for Disease Control and Prevention (U.S.). Immunization Safety Office. 3
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. 2
- National Center for Immunization and Respiratory Diseases (U.S.) 3
- National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division. 1
- National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division. 1
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. 3
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. 5
- National Center for Infectious Disease.(U.S.), Division of Viral and Rickettsial Diseases. 1
- National Center for Infectious Diseases (U.S.). Division of Vector-Borne Infectious Diseases. 1
- National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. 13
- National Center for Infectious Diseases (U.S.). Viral and Rickettsial Diseases Division. 1
- National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion., Immunization Safety Office. 1
- National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division. 1
- National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division. 2
- National Immunization Program (Centers for Disease Control and Prevention. Epidemiology and Surveillance Division. 1
- National Institute for Occupational Safety and Health. Division of Respiratory Disease Studies. 1
- United States, Advisory Committee on Immunization Practices. 4
- United States. Advisory Committee on Immunization Practices 1
- United States. Advisory Committee on Immunization Practices. 16
Place as Subject
- Illinois 1
- New Jersey 1
- Ohio 1
- Texas 1
- United States 11
- Wisconsin 1
Resource Type General
Resource Type Specific
x
Cox, Nancy (Nancy J.)
Select all docs
(Max 200)
(Max 200)
1 -
20 of 27 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Acetamides (1)
- administration & dosage (1)
- Adolescent (2)
- Adult (2)
- adverse effects (1)
- Aged (1)
- Amantadine (1)
- Animals (1)
- antagonists & inhibitors (1)
- Antigens, Viral / immunology (2)
- Antiviral Agents (7)
- Antiviral Agents / therapeutic use (10)
- Child (2)
- Child, Preschool (2)
- Contraindications (1)
- Cost of Illness (1)
- Cross Infection (2)
- Disease Outbreaks (6)
- Disease Outbreaks / prevention & control (8)
- Drug Interactions (1)
- Drug Resistance, Microbial (1)
- drug therapy (1)
- Enzyme Inhibitors (1)
- Female (1)
- Guanidines (1)
- HIV Infections (1)
- Humans (2)
- Immunization Programs (3)
- Immunization Schedule (4)
- Immunocompromised Host (1)
- Infant (2)
- Influenza (1)
- Influenza, Human (13)
- Influenza, Human / complications (1)
- Influenza, Human / drug therapy (9)
- Influenza, Human / epidemiology (3)
- Influenza, Human/epidemiology (1)
- Influenza, Human / prevention & control (6)
- Influenza, Human/prevention & control (1)
- Influenza / drug therapy (1)
- Influenza A virus (10)
- Influenza A Virus, H1N1 Subtype (2)
- Influenza A Virus, H1N1 Subtype / immunology (2)
- Influenza A Virus, H3N2 Subtype (2)
- Influenza A Virus, H3N2 Subtype / immunology (2)
- Influenza B virus (13)
- Influenza B virus / immunology (2)
- Influenza Vaccine (1)
- Influenza Vaccines (8)
- Influenza Vaccines / administration & dosage (12)
- Influenza Vaccines/administration & dosage (1)
- Influenza Vaccines / adverse effects (4)
- Influenza Vaccines/adverse effects (1)
- Influenza Vaccines / contraindications (1)
- Influenza Vaccines / immunology (2)
- Influenza Vaccines / supply & distribution (2)
- Influenza Vaccines adverse effects (1)
- Lyme Disease (1)
- Male (1)
- Mass Vaccination (9)
- Middle Aged (1)
- Neuraminidase (1)
- Oseltamivir (1)
- pharmacokinetics (1)
- Pneumococcal Vaccines / administration & dosage (2)
- Pneumococcal Vaccines / adverse effects (2)
- Pneumonia, Viral (1)
- Population Surveillance (3)
- Practice Guideline (1)
- Pregnancy (1)
- Public Health (1)
- Pyrans (1)
- Rimantadine (1)
- Risk Factors (1)
- Seasons (3)
- Seizures, Febrile / etiology (2)
- Sialic Acids (1)
- Silicosis (1)
- therapeutic use (1)
- United States / epidemiology (1)
- Vaccination (8)
- Vaccination / standards (8)
- Vaccines, Attenuated (2)
- Vaccines, Inactivated (4)
- Vaccines, Inactivated / administration & dosage (1)
- Vaccines, Inactivated / adverse effects (1)
- Zanamivir (1)
- Centers for Disease Control (U.S.), Immunization Practices Advisory Committee. (1)
- Centers for Disease Control and Prevention (U.S.) (21)
- Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Science. (1)
- Centers for Disease Control and Prevention (U.S.). Immunization Safety Office. (3)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. (2)
- National Center for Immunization and Respiratory Diseases (U.S.) (3)
- National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division. (1)
- National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division. (1)
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. (3)
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (5)
- National Center for Infectious Disease.(U.S.), Division of Viral and Rickettsial Diseases. (1)
- National Center for Infectious Diseases (U.S.). Division of Vector-Borne Infectious Diseases. (1)
- National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. (13)
- National Center for Infectious Diseases (U.S.). Viral and Rickettsial Diseases Division. (1)
- National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion., Immunization Safety Office. (1)
- National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division. (1)
- National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division. (2)
- National Immunization Program (Centers for Disease Control and Prevention. Epidemiology and Surveillance Division. (1)
- National Institute for Occupational Safety and Health. Division of Respiratory Disease Studies. (1)
- United States, Advisory Committee on Immunization Practices. (4)
- United States. Advisory Committee on Immunization Practices (1)
- United States. Advisory Committee on Immunization Practices. (16)
- :Gensheimer, Kathleen F. ;Fukuda, Keiji1999 Mar-Apr | Emerg Infect Dis. 5(2):297-299.
- :Bridges, Carolyn B. ;Cox, Nancy (Nancy J.)December 17, 1999 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):Influenza epidemics are responsible for an average of approximately 20,000 deaths per year in the United States. The main method for preventing influe...
- :Grohskopf, Lisa A. ;Shay, David K.September 20, 2013 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This report updates the 2012 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccines for ...:superseded
- :Grohskopf, Lisa A. ;Bresee, Joseph S.August 17, 2012 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ?6 months in the ...:superseded
- :Bresee, Joseph S. ;Broder, Karen R.July 31, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for t...:superseded
- :Arden, Nancy H. ;Cox, Nancy (Nancy J.)May 1, 1998 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 1998-99 influenza...
- :Bresee, Joseph S. ;Broder, Karen R.August 8, 2008 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates the 2007 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and ...:superseded
- :Bresee, Joseph S. ;Cox, Nancy (Nancy J.)July 13, 2007 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates the 2006 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and ...:superseded
- :Bridges, Carolyn B. ;Cox, Nancy (Nancy J.)April 20, 2001 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates the 2000 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral...:superseded
- :Bridges, Carolyn B. ;Cox, Nancy (Nancy J.)April 14, 2000 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral age...:superseded
- :Brammer, T . Lynnette ;Bridges, Carolyn B.April 30, 1999 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates 1998 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral age...
- :Harper, Scott ;Fukuda, KeijiJuly 29, 2005 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This report updates the 2004 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and ant...:superseded
- :Bridges, Carolyn B. ;Cox, Nancy (Nancy J.)April 12, 2002 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):superseded
- :Smith, Nicole M. ;Bresee, Joseph S.July 28, 2006 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates the 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and an...:superseded
- :Bresee, Joseph S. ;Broder, Karen R.August 6, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for ...:superseded
- :Arden, Nancy H. ;Cox, Nancy (Nancy J.)April 25, 1997 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 1997-98 influenza...:superseded
- :Arden, Nancy H. ;Cox, Nancy (Nancy J.)May 3, 1996 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1996-97 influenza season (...
- :Arden, Nancy H. ;Cox, Nancy (Nancy J.)April 21, 1995 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (...:superseded
- :Arden, Nancy H. ;Cox, Nancy (Nancy J.)May 27, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):These recommendations update information on the vaccine available for controlling influenza during the 1994-95 influenza season. The recommendations s...:superseded
- :Arden, Nancy H. ;Cox, Nancy (Nancy J.)May 14, 1993 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"These recommendations update information on the vaccine available for controlling influenza during the 1993-94 influenza season (superseding MMWR 199...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.